Clinical Trials Browser

Phase 1 × Solid Tumor Cancer × Temozolomide × Clear all

NCT06710821 2024-11-29

Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumor Cancer